ClinicalTrials.govpublic full text
Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC
gallbladder cancer, envafolimab(immune checkpoint inhibitor anti-pd-l1 antibody), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 995419
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.